Sekar Kathiresan

Insider Reports History

Location
South San Francisco, CA
Signature
/s/ Courtney Phillips, as attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Sekar Kathiresan:

Company Role Class Num Shares Value Price $ Report Date Ownership
Verve Therapeutics, Inc. Chief Executive Officer, Director Restricted Stock Units 0 $410,850 $4.15 25 Jul 2025 Direct
Verve Therapeutics, Inc. Chief Executive Officer, Director Common Stock 0 $0 $11.23 25 Jul 2025 Direct
Verve Therapeutics, Inc. Chief Executive Officer, Director Common Stock 0 $0 $11.23 25 Jul 2025 Kathiresan Family 2021 Irrevocable Trust
Verve Therapeutics, Inc. Chief Executive Officer, Director Common Stock 0 $0 $11.23 25 Jul 2025 Sekar Kathiresan 2021 Irrevocable Trust
Relay Therapeutics, Inc. Director Stock Option (Right to Buy) 136,681 06 Jun 2025 Direct
Maze Therapeutics, Inc. Director Common Stock 103,723 30 Jan 2025 Direct
Maze Therapeutics, Inc. Director Stock Option (Right to Buy) 18,000 22 Sep 2025 Direct
Verve Therapeutics, Inc. Chief Executive Officer, Director Stock Option (right to buy) 0 25 Jul 2025 Direct
Verve Therapeutics, Inc. Chief Executive Officer, Director Stock Option (right to buy) 0 25 Jul 2025 Sekar Kathiresan 2023 Annuity Trust

Insider Reports Filed by Sekar Kathiresan

Symbol Company Period Transactions Value $ Form Type Role Filing Time
MAZE Maze Therapeutics, Inc. 22 Sep 2025 1 $0 4 Director 24 Sep 2025, 16:16
VERV Verve Therapeutics, Inc. 25 Jul 2025 13 $0 4 Chief Executive Officer, Director 28 Jul 2025, 17:15
RLAY Relay Therapeutics, Inc. 06 Jun 2025 1 $0 4 Director 06 Jun 2025, 17:51
VERV Verve Therapeutics, Inc. 01 Apr 2025 3 -$40,761 4 Chief Executive Officer, Director 03 Apr 2025, 17:00
MAZE Maze Therapeutics, Inc. 30 Jan 2025 0 $0 3 Director 30 Jan 2025, 16:33
VERV Verve Therapeutics, Inc. 08 Jan 2025 3 $0 4 Chief Executive Officer, Director 10 Jan 2025, 09:00
VERV Verve Therapeutics, Inc. 04 Dec 2024 2 $0 4 Chief Executive Officer, Director 04 Dec 2024, 16:30
VERV Verve Therapeutics, Inc. 28 Jun 2024 2 +$86,100 4 Chief Executive Officer, Director 02 Jul 2024, 07:30
RLAY Relay Therapeutics, Inc. 03 Jun 2024 1 $0 4 Director 05 Jun 2024, 20:04
VERV Verve Therapeutics, Inc. 14 Feb 2024 2 $0 4 Chief Executive Officer, Director 16 Feb 2024, 16:30
RLAY Relay Therapeutics, Inc. 31 May 2023 1 $0 4 Director 01 Jun 2023, 18:39
VERV Verve Therapeutics, Inc. 14 Feb 2023 1 $0 4 Chief Executive Officer, Director 16 Feb 2023, 16:00
VERV Verve Therapeutics, Inc. 03 Oct 2022 5 -$1,613,122 4 Chief Executive Officer, Director 05 Oct 2022, 17:00
VERV Verve Therapeutics, Inc. 10 Aug 2022 3 -$1,425,500 4 Chief Executive Officer, Director 11 Aug 2022, 17:00
RLAY Relay Therapeutics, Inc. 25 Jul 2022 1 $0 4 Director 27 Jul 2022, 18:57
RLAY Relay Therapeutics, Inc. 25 Jul 2022 0 $0 3 Director 27 Jul 2022, 16:52
VERV Verve Therapeutics, Inc. 19 Jul 2022 3 -$1,425,500 4 Chief Executive Officer, Director 21 Jul 2022, 17:00
VERV Verve Therapeutics, Inc. 07 Jul 2022 6 $0 4 Chief Executive Officer, Director 15 Jul 2022, 17:00
VERV Verve Therapeutics, Inc. 18 Mar 2022 2 +$199,964 4 Chief Executive Officer, Director 22 Mar 2022, 07:41
VERV Verve Therapeutics, Inc. 11 Feb 2022 1 $0 4 Chief Executive Officer, Director 15 Feb 2022, 07:58
VERV Verve Therapeutics, Inc. 04 Jan 2022 3 -$72,014 4 Chief Executive Officer, Director 06 Jan 2022, 15:36
VERV Verve Therapeutics, Inc. 27 Dec 2021 8 -$1,887,851 4 Chief Executive Officer, Director 29 Dec 2021, 15:38
VERV Verve Therapeutics, Inc. 22 Dec 2021 9 -$4,322,144 4 Chief Executive Officer, Director 27 Dec 2021, 17:08
VERV Verve Therapeutics, Inc. 17 Jun 2021 2 +$47,500 4 Chief Executive Officer, Director 21 Jun 2021, 18:20
VERV Verve Therapeutics, Inc. 16 Jun 2021 0 $0 3 Chief Executive Officer, Director, 10%+ Owner 16 Jun 2021, 19:42